论文部分内容阅读
充血性心力衰竭是各种心脏病常见的严重后果之一。传统疗法是采用洋地黄和利尿药。随着血液动力学的研究进展,对心衰的病理生理有了较深入的了解;在此基础上,近几年来提出了扩血管疗法治疗心衰。心脏病学家Mason指出:在心血管内科中可能没有其他新疗法象扩血管药那样立即被用于临床实践,这将是治疗心衰的新开端,预计将象洋地黄一样成为常用疗法。为此本文就有关问题作一扼要介绍。
Congestive heart failure is one of the common serious consequences of various heart diseases. Traditional therapy uses digitalis and diuretics. With the progress of hemodynamics, the pathophysiology of heart failure have a more in-depth understanding; On this basis, in recent years, vasodilator therapy for the treatment of heart failure. Mason, a cardiologist, states: "There may not be any other new therapy in cardiovascular medicine that is immediately used in clinical practice like vasodilators. It will be a new beginning in the treatment of heart failure and is expected to become a common therapy as digitalis. To this end, this article makes a brief introduction on the related issues.